Healthcare Technologies posts August 2025 KPI update

Healthcare Technologies Inc. submitted a Form 6-K to notify investors that it issued a press release presenting updated major key performance indicators for August 2025.

Accepted by SEC EDGAR 09/24/2025 - 06:10 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Healthcare Technologies Inc. submitted a Form 6-K to notify investors that it issued a press release presenting updated major key performance indicators for August 2025. The press release, dated September 24, 2025, is furnished as Exhibit 99.1 and is not treated as filed or automatically incorporated into other securities law filings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Healthcare Technologies Inc. (MRM) disclose in this Form 6-K?

Healthcare Technologies Inc. uses this Form 6-K to inform investors that it has issued a press release presenting major key performance indicators for August 2025. The press release, dated September 24, 2025, is attached as Exhibit 99.1 for reference.

Which period do Healthcare Technologies Inc. (MRM) KPIs in this filing cover?

The key performance indicators highlighted in the referenced press release relate to the month of August 2025. Healthcare Technologies Inc. notes that the Form 6-K is being used solely to furnish updated monthly KPI information to the market through Exhibit 99.1.

Is the Healthcare Technologies Inc. (MRM) KPI press release considered filed with the SEC?

The company states that the information in this Form 6-K, including the KPI press release in Exhibit 99.1, is furnished rather than filed. As a result, it is not subject to Section 18 liabilities or automatically incorporated into other securities law filings.

Where can investors find the August 2025 KPI details for Healthcare Technologies Inc. (MRM)?

Investors can find the detailed August 2025 key performance indicators in Exhibit 99.1 to this Form 6-K. That exhibit is the press release dated September 24, 2025, in which Healthcare Technologies Inc. presents its updated major KPIs for the month.

Who signed the Healthcare Technologies Inc. (MRM) Form 6-K related to August 2025 KPIs?

The Form 6-K was signed on behalf of Healthcare Technologies Inc. by Fumitoshi Fujiwara. He is identified in the document as the company’s Chief Financial Officer and executed the report dated September 24, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2025

Commission File Number 001-39809

MEDIROM HEALTHCARE TECHNOLOGIES INC.

(Translation of registrant’s name into English)

2-3-1 Daiba, Minato-ku

Tokyo 135-0091, Japan

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

​

​

​

​

​

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Issuance of Press Release

On September 24, 2025, MEDIROM Healthcare Technologies Inc. (the “Company”) is issuing a press release announcing its major Key Performance Indicators, or KPIs, updated for the month of August 2025. A copy of the press release, dated September 24, 2025, is furnished as Exhibit 99.1 hereto.

The information furnished in this report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.

​

EXHIBIT INDEX

​

Exhibit No.		Description
99.1	​	Press release of the Company

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​

​	MEDIROM HEALTHCARE TECHNOLOGIES INC.
Date: September 24, 2025	​
​	By:	/s/ Fumitoshi Fujiwara
​	​	Name: Fumitoshi Fujiwara
​	​	Title: Chief Financial Officer

​